CatalystAlert vs ClinicalInvestor
Both track biotech catalysts. ClinicalInvestor Plain-English AI clinical-trial analysis for retail investors — paste a ClinicalTrials.gov ID for a readable interpretation, plus a catalyst calendar and 600+ company profiles. CatalystAlert CatalystAlert is a biotech catalyst intelligence platform tracking FDA decisions, PDUFA dates, and clinical-trial readouts for 1,600+ biotech stocks. Every catalyst date carries a confidence rating — confirmed against an official regulatory source, estimated, or AI-detected — alongside AI entry-timing and a public, scored prediction track record.
| Capability | CatalystAlert | ClinicalInvestor |
|---|---|---|
| FDA / PDUFA catalyst calendar | ||
| Per-date source-confidence labels | ||
| AI likelihood-of-approval (LOA) | ||
| AI entry-timing (pre-catalyst run-up) | ||
| Quantified per-event trade score | ||
| Institutional / 13F smart-money | ||
| Plain-English trial analysis | ||
| AI portfolio generation | ||
| Public, scored prediction track record | ||
| Free tier |
= verified on the tool's public site · = not advertised / not verified (check their site) · = not offered. Verified 2026-05-31; features & pricing change — confirm on each site. Corrections welcome.
- Its standout "trial translator": plain-English AI interpretation of a specific clinical trial.
- Strong educational content for investors new to reading trials — and a free tier.
- Per-date confidence labels — every catalyst date is marked confirmed (official regulatory source), estimated, or AI-detected, so you know how reliable each date is.
- AI entry-timing — a run-up conviction score for the pre-catalyst window, not just the event date.
- A public, scored prediction track record (likelihood-of-approval, stock-impact, entry-timing) measured against actual outcomes.
- Breadth: 1,600+ biotech & pharma companies and tens of thousands of tracked catalysts.
CatalystAlert: Free tier (calendar, watchlist, weekly digest); Pro $29.99/mo (full calendar, AI predictions, alerts, smart-money); Elite $99.99/mo (API).
ClinicalInvestor: Free tier; premium around $19/mo (7-day trial). Confirm current pricing on their site.
We aim for a fair comparison: details about ClinicalInvestor were taken from clinicalinvestor.com on 2026-05-31. If anything is out of date, the source of truth is their own site.
FAQ
Is CatalystAlert a good alternative to ClinicalInvestor?
CatalystAlert and ClinicalInvestor both track biotech catalysts (FDA decisions, PDUFA dates, clinical-trial readouts). ClinicalInvestor is strongest at: its standout "trial translator": plain-english ai interpretation of a specific clinical trial. CatalystAlert adds per-date confidence labels (confirmed / estimated / AI-detected), AI entry-timing for the pre-catalyst run-up, and a public, scored prediction track record. Which fits depends on whether you want ClinicalInvestor's focus or CatalystAlert's verifiability and entry-timing.
What does CatalystAlert add compared to ClinicalInvestor?
Entry-timing, likelihood-of-approval scores, and a public, scored prediction track record. Per-date confidence labels and broader company coverage (1,600+ vs ~600).
How much do CatalystAlert and ClinicalInvestor cost?
CatalystAlert: Free tier (calendar, watchlist, weekly digest); Pro $29.99/mo (full calendar, AI predictions, alerts, smart-money); Elite $99.99/mo (API). ClinicalInvestor: Free tier; premium around $19/mo (7-day trial). Confirm current pricing on their site.
Where do CatalystAlert's catalyst dates come from?
Every catalyst date carries a confidence label: "confirmed" (verified against an official regulatory source), "estimated" (e.g. ClinicalTrials.gov), or "AI-detected" (extracted from news, flagged to verify). Sources include FDA, SEC EDGAR and ClinicalTrials.gov.
See CatalystAlert's catalyst calendar
Sourced FDA & PDUFA dates with confidence labels, AI entry-timing, and a public track record.